Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun pathology A disorder caused by abnormal
metabolism ofcystine
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word cystinosis.
Examples
-
RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ( "DR Cysteamine") in patients with nephropathic cystinosis ( "cystinosis").
unknown title 2009
-
RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ( "DR Cysteamine") in patients with nephropathic cystinosis ( "cystinosis").
unknown title 2009
-
RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ( "DR Cysteamine") in patients with nephropathic cystinosis ( "cystinosis").
unknown title 2009
-
RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ( "DR Cysteamine") in patients with nephropathic cystinosis ( "cystinosis").
unknown title 2009
-
RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ( "DR Cysteamine") in patients with nephropathic cystinosis ( "cystinosis").
unknown title 2009
-
RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ( "DR Cysteamine") in patients with nephropathic cystinosis ( "cystinosis").
unknown title 2009
-
Christy Greeley of Lincolnshire, Ill., said the drug Cystagon has saved lives of children with nephropathic cystinosis, including her 11-year-old son.
Many 'Orphan Drugs' Get Expedited Review by FDA Thomas M. Burton 2011
-
Raptor's clinical programs include DR Cysteamine for the potential treatment of nephropathic cystinosis, non-alcoholic steatohepatitis "NASH", and Huntington's Disease.
unknown title 2011
-
For some background, on June 6, the company announced that on June 3 the last clinical trial patient visits were completed and final data analysis will commence this week on the Phase 3 clinical trial of its delayed-release oral formulation of DR Cysteamine in patients with cystinosis.
unknown title 2011
-
The pivotal Phase 3 clinical trial is designed as an outpatient study of the safety, tolerability, pharmacokinetics ("PK") and pharmacodynamics ("PD") of every 12-hour DR Cysteamine compared to every 6-hour immediate-release cysteamine bitartrate in cystinosis patients.
unknown title 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.